Effect of medical treatment on outcome of benign prostatic hyperplasia in patients followed in the University Teaching Hospital of Kigali

• DOI: 10.4314/rmj.v81i4.6
• Publication Date: 2025-01-16T10:09:42Z
• Authors: A. Bonane; A. Nyirimodoka; T. Hategekimana; Y. C. Bizumuremyi; I. M. V. Niyonkuru; J. Rickard

INTRODUCTION: Management of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) includes watchful waiting, pharmacotherapy, and surgical intervention. This study aimed determine the effect medical therapy on LUTS in patients with BPH Rwanda. METHODS: was a one-year prospective observational men over 40 years BPH. Patients were followed at 1, 3, 6 months. We recorded post-void residual urine (PVR), prostate size, International Prostate Symptom Score (IPSS), medications. Logistic regression analyses used assess relationship between treatment outcomes interest. RESULTS: A total 163 enrolled. Adherence 151/154 (98%) one month 133/151 (88%) The reason no adherence ignorance 11/17 (65%), drug not available 3/17 (18%), 2/17 (12%) lacking money. Medical associated decrease IPSS score more than 4 points after 3 months statistically significant adjusting initial size as confounder (p =0.01 p=0.02, respectively). also mean PVR months, respectively (p: 0.03 p 0.04 months). CONCLUSION: for decreased offers an alternative low-resource areas limited services. Advocacy efforts should focus ensuring affordable access these